News & Events

FEBRUARY 25, 2025

Our recently published manuscript reviews the current landscape and key hurdles faced in ONTs and offers antibody-based assays as an othogonal approach for localization and quantification of ONTs throughout drug development.

FEBRUARY 3, 2025

The AccuSignal E. coli ELISA Kit is designed to detect E. coli Host Cell Proteins (HCPs), including from strains such as B and K-12, to ensure bioprocess consistency and safety of therapeutic products.

OCTOBER 25, 2024

Abzyme Therapeutics LLC, a Rockland-affiliated biotechnology company, has reached a significant milestone in its pursuit to develop innovative antibody-based therapies.

AUGUST 22, 2024

The Jackson Laboratory Expands Partnership with Rockland and antibodies-online to Exclusively Offer Highly Characterized FcRn Antibodies for the Assessment of Therapeutic Drugs.

APRIL 16, 2024

The Jackson Laboratory partners with Rockland and antibodies-online to provide genomic tools for global immuno-oncology research, diagnostics, and therapeutics development.

JANUARY 11, 2024

The AccuSignal Nuclease ELISA Kit is designed to detect endonuclease to evaluate manufacturing processes for biological therapeutics, gene therapy vectors, vaccine preparations, and more.

OCTOBER 17, 2023

The first and only panel of specialty reagents designed to detect PS modifications independent of sequence, format, or location, streamlining candidate triage for unparalleled cost and time savings in early-stage non-clinical and pre-clinical discovery assessment of...

FEBRUARY 1, 2023

Rockland, a pioneer in life science solutions, is excited to announce the initiation of the Early Access Program for its ModDetect Anti-PS Monoclonal Antibody Panel.

NOVEMBER 10, 2022

In partnership with Cytiva Life Sciences, Rockland is announcing the newest addition to the portfolio - the PrismA ELISA kit. This new kit is designed to reduce the complexity in process-related impurity analytical assay development.

FEBRUARY 22, 2022

Rockland Immunochemicals, Inc. (Rockland) and the Jefferson Institute for Bioprocessing (JIB) announced today that an agreement has been signed under which both entities are able to utilize one another's strengths to provide complete and scalable bioprocessing solutio...

FEBRUARY 10, 2022

With its acquisition of antibodies-online GmbH, Rockland expands its capabilities, product portfolio, and geographic footprint to serve scientists engaged in the discovery, development, and delivery of complex therapies and critical diagnostics ...

OCTOBER 18, 2021

Diagnostic BioSystems (DBS), a provider of cutting-edge in vitro diagnostics and high quality Immunohistochemistry (IHC) reagents has signed a distribution agreement with Rockland Immunochemicals, Inc ...

SEPTEMBER 28, 2021

Rockland President and Chief Executive Officer, James Fendrick and the King Abdullah International Medical Research Center (ك KAIMRC) recently signed a Memorandum ...

SEPTEMBER 9, 2020

Introducing CRISPR in a Box - it is not a new crunchy cereal or the latest snack - it is an educational tool kit consisting of state-of-the-science gene editing technology that could be coming to a school near you ...

AUGUST 12, 2020

Rockland greatly values our local partnerships-one in particular is our partnership with Montgomery County Community College (MCCC) and their Biotechnology Associate Professor and Program Coordinator, Dr. Margaret Bryans ...

MAY 29, 2020

Rockland Immunochemicals Inc. has developed a critical antibody reagent essential to antibody tests used to determine SARS-CoV-2 exposure for patients suspected to have contracted COVID-19 ...

MARCH 16, 2020

At Rockland, we are adjusting our business operations to account for the coronavirus (COVID-19) pandemic. We want you, our customers, to know our plans ...